Viewing Study NCT02955251


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-02-26 @ 4:30 PM
Study NCT ID: NCT02955251
Status: COMPLETED
Last Update Posted: 2020-07-20
First Post: 2016-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Neoplasm View
None Advanced solid tumor View
None Nivolumab View
None Non-small cell lung cancer (NSCLC) View
None Non-squamous NSCLC View
None Ovarian cancer View